References
1. Das M, Loveday JJ, Wynn GJ, Gomes S, Saeed Y, Bonnett LJ, et al. Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values. EP Europace2017;19 :775–83.
2. Hussein A, Das M, Riva S, Morgan M, Ronayne C, Sahni A, et al.Use of Ablation Index-Guided Ablation Results in High Rates of Durable Pulmonary Vein Isolation and Freedom From Arrhythmia in Persistent Atrial Fibrillation Patients: The PRAISE Study Results. Circ Arrhythm Electrophysiol 2018;11 :e006576.
3. Duytschaever M, De Pooter J, Demolder A, El Haddad M, Phlips T, Strisciuglio T, et al. Long-term impact of catheter ablation on arrhythmia burden in low-risk patients with paroxysmal atrial fibrillation: The CLOSE to CURE study. Heart Rhythm2020;17 :535–43.
4. Taghji P, El Haddad M, Phlips T, Wolf M, Knecht S, Vandekerckhove Y,et al. Evaluation of a Strategy Aiming to Enclose the Pulmonary Veins With Contiguous and Optimized Radiofrequency Lesions in Paroxysmal Atrial Fibrillation: A Pilot Study. JACC Clin Electrophysiol2018;4 :99–108.
5. Duytschaever M, Vijgen J, De Potter T, Scherr D, Van Herendael H, Knecht S, et al. Standardized pulmonary vein isolation workflow to enclose veins with contiguous lesions: the multicentre VISTAX trial.Europace 2020;22 :1645–52.
6. Kotadia ID, Williams SE, O’Neill M. High-power, Short-duration Radiofrequency Ablation for the Treatment of AF. Arrhythm Electrophysiol Rev 2020;8 :265–72.
7. Berte B, Hilfiker G, Russi I, Moccetti F, Cuculi F, Toggweiler S,et al. Pulmonary vein isolation using a higher power shorter duration CLOSE protocol with a surround flow ablation catheter. J Cardiovasc Electrophysiol 2019;30 :2199–204.
8. Huo Y, Gaspar T, Pohl M, Sitzy J, Richter U, Neudeck S, et al.Prevalence and predictors of low voltage zones in the left atrium in patients with atrial fibrillation. Europace2018;20 :956–62.
9. Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S,et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol 2005;45 :285–92.
10. Rolf S, Kircher S, Arya A, Eitel C, Sommer P, Richter S, et al. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 2014;7 :825–33.
11. Yarlagadda B, Deneke T, Turagam M, Dar T, Paleti S, Parikh V,et al. Temporal relationships between esophageal injury type and progression in patients undergoing atrial fibrillation catheter ablation. Heart Rhythm 2019;16 :204–12.
12. Wielandts J-Y, Kyriakopoulou M, Almorad A, Hilfiker G, Strisciuglio T, Phlips T, et al. Prospective Randomized Evaluation of High Power During CLOSE-Guided Pulmonary Vein Isolation: The POWER-AF Study.Circ Arrhythm Electrophysiol 2021;14 :e009112.
13. Kottmaier M, Popa M, Bourier F, Reents T, Cifuentes J, Semmler V,et al. Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Europace2020;22 :388–93.
14. Reddy VY, Grimaldi M, De Potter T, Vijgen JM, Bulava A, Duytschaever MF, et al. Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial.JACC Clin Electrophysiol 2019;5 :778–86.
15. Gupta A, Perera T, Ganesan A, Sullivan T, Lau DH, Roberts-Thomson KC, et al. Complications of catheter ablation of atrial fibrillation: a systematic review. Circ Arrhythm Electrophysiol2013;6 :1082–8.
16. Luckie M, Jenkins NP, Davidson NC, Chauhan A. Dressler’s syndrome following pulmonary vein isolation for atrial fibrillation. Acute Card Care 2008;10 :234–5.
17. Schoene K, Arya A, Grashoff F, Knopp H, Weber A, Lerche M, et al. Oesophageal Probe Evaluation in Radiofrequency Ablation of Atrial Fibrillation (OPERA): results from a prospective randomized trial.Europace 2020;22 :1487–94.
18. Kaneshiro T, Kamioka M, Hijioka N, Yamada S, Yokokawa T, Misaka T,et al. Characteristics of Esophageal Injury in Ablation of Atrial Fibrillation Using a High-Power Short-Duration Setting. Circ Arrhythm Electrophysiol 2020;13 :e008602.
19. Kapur S, Barbhaiya C, Deneke T, Michaud GF. Esophageal Injury and Atrioesophageal Fistula Caused by Ablation for Atrial Fibrillation.Circulation 2017;136 :1247–55.
20. Halbfass P, Pavlov B, Müller P, Nentwich K, Sonne K, Barth S,et al. Progression From Esophageal Thermal Asymptomatic Lesion to Perforation Complicating Atrial Fibrillation Ablation: A Single-Center Registry. Circ Arrhythm Electrophysiol 2017;10 .
21. Chen S, Schmidt B, Bordignon S, Urbanek L, Tohoku S, Bologna F,et al. Ablation index-guided 50 W ablation for pulmonary vein isolation in patients with atrial fibrillation: Procedural data, lesion analysis, and initial results from the FAFA AI High Power Study.Journal of Cardiovascular Electrophysiology2019;30 :2724–31.